This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 October-5 November 2022 and includes updates on chikungunya, dengue, COVID-19, increase in hepatitis cases in children, monkeypox, West Nile virus, Ebola virus disease due to Sudan ebolavirus, and seasonal influenza.
Version 6.1 is the final protocol for the third EU-wide point prevalence survey in acute care hospitals (PPS 2022–2023). It contains important changes compared to protocol version 5.3 (PPS 2016–2017), including on healthcare-associated COVID-19.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 25 September - 1 October 2022 and includes updates on COVID-19, Ebola, West Nile Virus, Chikungunya and dengue, influenza A, swine flu, and hepatitis.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21-27 August 2022 and includes updates on monkeypox, West Nile virus, COVID-19, Ebola, Vibrio growth, diphtheria, cholera, chikungunya virus disease and dengue.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 24 -30 July and includes updates on COVID-19, monkeypox, West Nile virus, increase in hepatitis of unknown aetiology in children, mass gatherings in the Birmingham 2022 Commonwealth games, Vibrio growth, Marburg disease, Chikungunya, dengue, and wild poliovirus.
This key provides the non-specialist with reference material to help recognise an invasive mosquito species and gives details on the morphology to help with verification.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 26 June-2 July 2022 and includes updates on West Nile virus infection, COVID-19, hepatitis, monkeypox, plague, dengue, polio, chikungunya and cholera.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 29 May-4 June 2022 and includes updates on West Nile virus infection, COVID-19, Influenza, people displaced from Ukraine, hepatitis, Ebola, monkeypox, cholera, chikungunya and dengue.